Massive asthma registry aims to unlock secrets of severe disease
NCT ID NCT06625216
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that will collect information from 5,000 people with severe asthma over time. The goal is to better understand the disease, how well patients follow their treatment plans, and how different biologic medications work in everyday life. Participants must be over 12 years old and have a confirmed diagnosis of severe asthma.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital, Rozzano, Italy
RECRUITINGRozzano, Milano, 20089, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single injection tame severe asthma in fungal allergy?
- Could a simple exercise programme boost asthma remission?
- A two-step strategy: biologic drug may pave the way for immunotherapy in severe olive pollen asthma
- Could a biologic drug free severe asthma patients from High-Dose steroids?
- Scientists probe why tezepelumab doesn't stop all asthma attacks
- Smart inhalers track Fasenra's asthma control over full dosing cycle